Monthly Archives: February 2020

Theralase Technologies Awarded 2020 TSX Venture 50

TORONTO, ON / ACCESSWIRE / February 20, 2020 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds ("PDC") and associated drug formulations, is pleased to announce today that Theralase has been named a 2020 TSX Venture 50™ company.

Presented by the TSX Venture Exchange, Theralase is ranked number eight in the Clean Technology & Life Sciences sector. This award recognizes the top 10 performing companies from five industry sectors selected based on three equally weighted criteria: market capitalization growth, share price appreciation and trading volume amount. Theralase was previously named a TSX Venture 50™ company in 2015 & 2019 making this the third year Theralase has been recognized as a top performer in the Clean Technology & Life Sciences sector.

On February 21, 2020, Theralase will be ringing the market opening bell with all the other TSX Venture 50™ companies at the Toronto Stock Exchange.

Shawn Shirazi, Ph.D., CEO of Theralase stated that "It is an honour to be recognized as an elite company on the TSX Venture for the third year. This achievement is a strong demonstration of the value that the Company has delivered to shareholders the preceding year. In 2019, Theralase reached a new milestone where a single treatment from Phase Ib Non-Muscle Invasive Bladder Cancer ("NMIBC") clinical study has achieved "cancer free" status, a complete response to treatment, at 18 months post treatment at therapeutic dose of TLD-1433 in 67% of patients presenting with Bacillus Calmette Guerin ("BCG")-Unresponsive NMIBC. Additionally, the Pivotal Phase II NMIBC clinical study has been rapidly progressing in Canada with 10 patients treated, to date, surpassing the expected enrollment timeline. We will continue to go above and beyond, reaching new milestones this year."

Please click the link to see TSX Venture 50™ interview with CEO of Theralase, Shawn Shirazi: For more information, visit:

About Study II

The Phase II NMIBC Clinical Study utilizes the Therapeutic Dose (0.70 mg/cm2) of TLD-1433, focusing on the treatment of approximately 100 BCG-Unresponsive NMIBC patients presenting with CIS in approximately 20 clinical study sites located in Canada and the US. Study II will have a primary endpoint of efficacy (measured by CR) at any point in time, a secondary endpoint of duration of CR at approximately 360 days post-initial treatment and a tertiary endpoint of safety measured by incidence and severity of adverse events grade 4 or higher that do not resolve within 360 days post-initial treatment. To date, 3 clinical study sites are active for enrollment and 10 patients have been treated in the Pivotal Phase II NMIBC Clinical Study.

About NMIBC:

In 2020, an estimated 81,400 adults (62,100 men and 19,300 women) will be newly diagnosed with bladder cancer in the United States. Among men, bladder cancer is the fourth most common cancer. It is estimated that 17,980 deaths (13,050 men and 4,930 women) from this disease will occur in 2020.1 The bladder cancer market is expected to triple in size to around $1.1 billion by 2025.2

About Theralase® Technologies Inc.

Theralase® is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers.

Additional information is available at and

1 Key Statistics for Bladder Cancer. Accessed January 29, 2020.

2 Bladder cancer market size to more than triple to over $1.1 billion by 2025. (2017). Retrieved 14 August 2019, from

Forward Looking Statement:

This news release contains "forward-looking statements" which reflect the current expectations of the Company's Management for future growth, results of operations, performance, business prospects and opportunities. Such statements include, but are not limited to, statements regarding the Company's proposed development plans with respect to Photo Dynamic Compounds and their drug formulations. Wherever possible, words such as "may", "would", "could", "should", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions including with respect to the ability of the Company to adequately fund, secure the requisite regulatory approvals to commence and successfully complete a Phase II NMIBC clinical study in a timely fashion and implement its development plans. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements; including, without limitation, those listed in the filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at Should one or more of these risks or uncertainties materialize or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the press release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. The Company disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For More Information:

1.866.THE.LASE (843-5273)
416.699.LASE (5273)

Shushu Feng, Investor Relations & Public Relations Coordinator
Amelia Tudo, Investor Relations & Public Relations Coordinator

SOURCE: Theralase Technologies Inc.

ReleaseID: 577156

Sales of Electric Sub-meters to Reach US$ 24 Bn by 2029, with Upswing in Adoption of Automation and Smart Solution Services, Reports Future Market Insights

Stakeholders in electric sub-meters market must target government contracts for smart electric sub-meters to leverage expansion opportunities and regional presence.

DUBAI, UAE / ACCESSWIRE / February 20, 2020 / In view of growing demand in the energy and utilities industry, the global electric sub-meters market is projected to hurtle towards US$ 24 Bn mark by the end of the forecast period (2019-2029). The electric sub-meters market is set to display a promising rate of growth through 2029, as suggested by a new Future Market Insights (FMI) study. Electric sub-meters are projected to witness heightened adoption in the energy and utilities industry on back of its superior energy efficiency and performance, concludes the FMI study.

"Manufacturers from ASEAN countries and India are focusing on acquiring new orders and tenders to increase their revenue by deploying smart electric sub-meters. This is creating ample opportunities for investors in the electric sub-meter market," says the FMI analyst.

Download PDF sample of the 291-page report on the electric sub-meters market

Key Takeaways of the Electric Sub-meters Study

The rising adoption of smart electric sub-meters with IoT capabilities is driving players to acquire component producers.
The lack of adequate technical expertise to adopt smart sub-meters is encouraging mergers with automation providers.
Mergers and acquisitions are projected to be the key business strategies for manufacturers in the industry.
East Asia is projected to hold a major market share throughout the forecast period, primarily driven by an impetus from China.

Electric Sub-meters Market – Top Growth Drivers

Government policies regarding installation of smart electric sub-meters would be a major growth driver.
Easy availability of low-cost smart electric sub-meters for residential applications will bolster overall demand.
Tech advancements to cut down electrical leaks and outages while reducing the risk of error, will continue to drive adoption.

Electric Sub-meters Market – Key Restraints

Reluctance of building owners towards paying the upfront costs of upgrading sub-meters is a key restraint to the market.
Conventional electric sub-meters continue to generate a greater risk of human error in records, thereby restricting the market.

Competitive Landscape

Some of the prominent players that are covered by the study include, but are not limited to, Schneider Electric, General Electric, Siemens AG, Mitsubishi Electric Corporation, Itron Inc., Honeywell International, Xylem Inc., OSAKI Electric Co. Leading players in the field of automation are acquiring sub-meter manufacturers to bolster scope of application. Further, regional manufacturers are pushing for product value additions, and competitive pricing strategies to bolster overall demand.

Explore 43 tables and 161 figures in the study. Request ToC of the report at

More about the Report

The 291-page study offers an in-depth market forecast and analysis on the electric sub-meters market. The major categories encompassed by the report include product type (socket type/electromechanical sub-meters, non-socket/electronic sub-meters, and smart sub-meters), phase (single phase and three phase), application (commercial establishments, residential sector, and industrial sector) across seven regions (South Asia, East Asia, Latin America, Europe, North America, Middle East & Africa, and Oceania).

Explore Extensive Coverage of FMI's Industrial Automation & Equipment Landscape

Robotic Grippers Market– Get FMI's latest growth predictions on the global robotic grippers market with exclusive assessment of market dynamics, taxonomy, historic, current, and future growth prospects of the global robotic grippers market.

Commercial Refrigeration Equipment Market– FMI's comprehensive documentation of the global commercial refrigeration equipment market covers segmental analysis, market performance, key trends, and prominent players with their respective market shares, developmental strategies, and business models.

Machine Tool Touch Probe Market– Obtain accurate quantitative and qualitative insights on the global machine tool touch probe market encompassing revenue statistics, successful market strategies, competitive landscape, key regions, and growth drivers for 2018-2028 projection period.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in U.S. and India. FMI's latest market research reports and industry analysis helps businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.


Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries:
For Media Enquiries:
Market Report:
Press Release Source:

SOURCE: Future Market Insights

ReleaseID: 577147

American Premium Water Corp (OTC:HIPH) Announces New Research Update Issued by Goldman Small Cap Research

The price target of $0.0125 comes after the Company recently completed the acquisition of distribution agreement with Q4 Sports

BALTIMORE, MD / ACCESSWIRE / February 20, 2020 / American Premium Water Corporation (OTC PINK:HIPH) announces today that Goldman Small Cap Research, a sponsored research provider focused on microcap stocks, has issued a new research update this morning. This update highlights the impact of the Company closing its distribution agreement with Q4 Sports ( In the sponsored research update, analyst Rob Goldman affirms his price target of $0.0125 and his investment thesis, noting that the news reflects a milestone event that is wide-reaching for the Company in terms of revenue, cross-selling opportunities, and a reach into new markets.

"In our view, this news serves as a transformational event for HIPH. First, it will foster cross-selling opportunities for HIPH that leverages the Q4 platform which could evolve into new, additional distribution. Second, HIPH can now reach a diverse and new demographics for its CBD offerings—that has heretofore not been widely targeted by HIPH's peers, " according to the Goldman Small Cap Research update.

Goldman also cited in the update that since his initiation of coverage report released on February 13, 2020, the HIPH stock price has already risen by 28%, with room to move much higher, based on future business development and revenue expectations. Both the report and the update, along with the associated disclosure and disclaimers can be read or downloaded on the Goldman Small Cap Research website here.

About Goldman Small Cap Research:

Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.

Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.

This press release contains excerpts of our most recently published sponsored company research report on American Premium Water Corporation., which carries a price target. The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research relied solely upon information derived from American Premium Water Corporation ("the Company") authorized press releases or legal disclosures made in its filings with the U.S. Securities and Exchange Commission

Separate from the factual content of our report about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities. Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.

A Goldman Small Cap Research report, update, newsletter, article, trading alert, corporate profile, or press release is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed is to be used for informational purposes only. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other regulatory agency. To download this research report or any of our research, view our disclosures and disclaimers, or for more information, visit Goldman Small Cap Research has been compensated by the Company in the amount of $3250 for a research subscription service, including the production of this press release, by a third party.


This press release and the associated Opportunity Research report was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research and Goldman Opportunity Research. The Select format reflects the Firm's internally generated stock ideas along with economic and stock market outlooks. Opportunity Research reports, updates and Microcap Hot Topics articles reflect sponsored (paid) research but can also include non-sponsored micro-cap research ideas that typically carry greater risks than those stocks covered in the Select Research category. It is important to note that while we may track performance separately, we utilize many of the same coverage criteria in determining coverage of all stocks in both research formats. Research reports on profiled stocks in the Opportunity Research format typically have a higher risk profile and may offer greater upside.

The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report or note is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. This report does not take into account the investment objectives, financial situation, or particular needs of any particular person.

This report referred to herein does not provide all information material to an investor's decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA, the U.S. Securities and Exchange Commission or with any state securities regulatory authority.


About American Premium Water Corp.

American Premium Water (OTC: HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company's portfolio includes the LALPINA Hydro and LALPINA CBD brands (, Q4 Sports (, Gents (, Vanexxe ( and plant + body essentials (

American Premium Water strives in providing only the highest quality CBD sources for its products, with quality control being one of our first and foremost focuses. The Company aims for this standard not only for compliance reasons, but also to provide our customers the highest quality product possible.

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.

Investor Relations Contact

SOURCE: American Premium Water Corporation

ReleaseID: 577154

Duos Technologies to Ring Nasdaq Opening Bell on Friday, February 21, 2020

JACKSONVILLE, FL / ACCESSWIRE / February 20, 2020 / Duos Technologies Group, Inc. (NASDAQ:DUOT) ("Duos" or the "Company"), a provider of intelligent analytical technology solutions, will ring the Nasdaq Opening Bell on Friday, February 21, 2020.

Select members of the Duos senior leadership team, legal counsel, and investment bankers will join Chairman and CEO Gianni Arcaini to ring the Nasdaq Opening Bell.

"This ceremony represents the culmination of many years of hard work, focus, and determination from our collective Duos team," said Arcaini. "We appreciate the support of our employees, partners, customers and shareholders who have all contributed to making our Nasdaq listing a reality. We will look to leverage our elevated profile into continued growth and success as a nationally listed company in the months ahead."

The ceremony will be held at Nasdaq's MarketSite in New York City and will be webcast starting at 9:15 a.m. Eastern time on Nasdaq's website (click here to watch), on Nasdaq's Facebook, and Twitter: @Nasdaq.

Nasdaq will also display a 30-second video that will run on Nasdaq's seven-story Video Tower and Marquee. The video will run on rotation exclusively for Duos for one full hour – "the hour of the opening bell."

The last two minutes of the ceremony will also be broadcasted live through major financial television networks such as CNBC, Fox Business News, Bloomberg TV, and BNN.

About Duos Technologies Group, Inc.

Duos Technologies Group, Inc. (NASDAQ:DUOT), based in Jacksonville, Florida, through its wholly owned subsidiary, Duos Technologies, Inc., provides advanced, analytical technology solutions with a strong portfolio of intellectual property. The Company's core competencies include intelligent technologies that combine machine learning, artificial intelligence and advanced video analytics that are delivered through its proprietary integrated enterprise command and control centraco® platform. The Company provides its broad range of technology solutions with an emphasis on mission critical security, inspection and operations within the rail transportation, retail, petrochemical, government, and banking sectors. Duos Technologies also offers professional and consulting services for large data centers. For more information, visit

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at

Forward Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking terminology such as "believes," "expects," "may," "will," "should," "anticipates," "plans," or similar expressions or the negative of these terms and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause Duos Technologies Group, Inc.'s actual results to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to, those described in Item 1A in Duos' Annual Report on Form 10-K, which is expressly incorporated herein by reference, and other factors as may periodically be described in Duos' filings with the SEC.



Tracie Hutchins
Duos Technologies Group, Inc.
(904) 652-1601

Investor Relations
Matt Glover or Tom Colton
Gateway Investor Relations
(949) 574-3860

SOURCE: Duos Technologies Group, Inc.

ReleaseID: 577081

PARP Inhibitor Sales to Exhibit Significant CAGR Through 2026; Investments in Cures for Cancer to Drive Wider Adoption, Reports Future Market Insights

Market leaders are laying greater strategic emphasis on activities such as capacity expansion, R&D, product portfolio and regional presence, through mergers, acquisitions, and collaborations.

DUBAI, UAE / ACCESSWIRE / February 20, 2020 / The global poly ADP ribose polymerase (PARP) inhibitors market is poised for an exponential growth at a CAGR of 15% during the forecast period (2019-2026). Strong demand from the flourishing pharmaceutical industries a key contributor for this growth projection. PARP inhibitors have gained noteworthy momentum owing to increased awareness about efficacy in terms of treating different types of cancer.

"The unique ability of PARP inhibitors to improve progression-free survival in ovarian and breast cancer patients is expected to generate extensive traction for the market, thereby propelling the growth of the global PARP inhibitors market over the forecast period," forecasts the FMI report.

Request sample of this report at

Key Takeaways of PARP Inhibitors Market Study

Olaparib is projected to dominate the global PARP inhibitors market owing to its applications in ovarian cancer, breast cancer, and pancreatic cancer.
A number of PARP inhibitors are up for imminent approval owing to a new drug application process.
PARP inhibitors are rapidly gaining traction as a new care standard of ovarian cancer treatment following platinum chemotherapy.
North America and Europe are projected to remain the dominant regional PARP inhibitors markets owing to better access to new technology and reimbursement policies.
Centralizing access to virtual and physical care with the aid of startups, research institutes and government bodies will play a key role in role for the future.

PARP Inhibitors Market – Top Growth Drivers

The rising burden of the different cancer types is a key driver behind the demand for PARP inhibitors.
The superior efficacy of PARP inhibitors over that of other cancer treatments is expected to drive revenue generation in the forecast period.
Faster approval of PARP inhibitor drugs are also anticipated to drive adoption rates, as demand rises.

PARP Inhibitors Market – Key Restraints

High costs related to clinical trials, insurance coverage, and testing for drug-drug interactions is a key restraint, particularly for emerging players.
The nascent nature of the PARP inhibitors market also builds the risk of such dosages not being included in select electronic records.

Schedule a meeting with expert analysts for detailed insights

Competitive Landscape

Some of the key market players profiled in the report include, but are not limited to TESARO Inc., AbbVie Inc., Pfizer Inc., AstraZeneca, CLOVIS ONCOLOGY. Mergers and acquisitions are the key developmental strategies being adopted by leading market players, as the market is projected to remain in a consolidated stage through the forecast period. Such moves will enable manufacturers to widen their scope of regional product offerings. For instance, TESARO Inc., was acquired by Glaxo Smith Kline plc which allowed the latter to expand its product portfolio with the inclusion of Zejula (Niraparib) PARP inhibitor.

More About the Report

The 200-page study offers an in-depth market forecast and analysis on PARP inhibitors market. The major categories encompassed by the report include drug (olaparib, niraparib, rucaparib, and talazoparib), indication (ovarian cancer, breast cancer, prostate cancer, and pancreatic cancer), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies) across seven regions (Middle East & Africa, Oceania, Europe, Latin America, South Asia, East Asia, North America).

Explore Extensive Coverage of FMI's Healthcare, Pharmaceuticals and Medical Devices Landscape

Liquid Biopsy Market– FMI's comprehensive analysis on the global liquid biopsy market helps stakeholders identify challenges and opportunities. The study covers key regions, competitive landscape, winning imperatives, and key recommendations.

Narcolepsy Treatment Market– Get actionable insights on the global narcolepsy treatment market covering important market dynamics, current and historical growth parameters, and future growth prospects for 2018-2028.

Protein Expression Technology Market– Find a deep-dive analysis of the global protein expression technology market encompassing market performance parameters, key trends, revenue forecast, and value projection along with market share analysis of key players.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.


Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

For Sales Enquiries:
For Media Enquiries:
Market Report:
Press Release Source:

SOURCE: Future Market Insights

ReleaseID: 577142

Demand for Cheese Packaging to Account for over US$ 5 Bn through 2029; Plastics Are Still Preferred, Finds Future Market Insights in a New Study

Influential players must focus their strategic efforts on improved research funding and innovations to create cost-effective and sustainable packaging materials for cheese packaging.

DUBAI, UAE / ACCESSWIRE / February 20, 2020 / Global cheese packaging market is set for healthy growth during 2019 – 2029, with revenues projected to expand 1.8X during the forecast period. The market will cross revenues worth US$ 5 Bn by the end of 2029, as indicated by a new report of Future Market Insights (FMI). Accelerated consumption of ready-to-eat cheese is significantly influencing this demand. Increase in penetration of modern retail across the globe is accountable for increase in sales of packaged cheese products, further bolstering the cheese packaging market growth.

"Retail industry has brought in the trend of ready-to-eat food products, surging the sale and demand in cheese packaging market," says the FMI report.

For more insights into the Market, request a sample of this report@

Key Takeaways of Cheese Packaging Market Study

Plastics will continue leading the market as a preferred packaging material
Trays & flow wraps are set to generate greater market revenue in the forecast period
A majority of cheese packaging demand is concentrated at hypermarkets and supermarkets
E-commerce expansion is creating an influx of opportunities for leading market players
With one-third market share, Europe continues to lead its way in the cheese packaging market

Cheese Packaging Market – Top Growth Drivers

Increasing consumption of on-the-go cheese products is primarily driving the market
Advanced packaging technologies such as vacuum packaging and modified atmospheric packaging are generating growth opportunities
Advanced storage methodologies for long-distance transport of packaged cheese products are bolstering market growth

Cheese Packaging Market – Key Restraints

High price of raw materials continues to negatively influence supply chain and restraining the market growth

Competition Landscape of Cheese Packaging Market

Some of the prominent players in the global cheese packaging landscape that are covered in this study include, but are not limited to, Winpak Ltd., Beery Global Inc., Sonoco Products Company, Kendall Packaging Corporation, Portco Packaging, Synpac Limited and Safepack industries Ltd. Manufacturers are investing in specialty packaging capable of providing protection against food spoiling agents such as moisture, air and microbial activity. Owing to increasing demand for safe and small packaging, market players are making investments in developing variety of flexible and aseptic packaging.

Download Methodology of this Report @

More about the Report

This Future Market Insights study of 244 pages offers actionable insights on cheese packaging market. The market analysis is based on packaging format (boxes, cups, pouches, trays and flow wraps, containers and lids & foil), material (plastic, paper, aluminum and glass) and distribution channel (e-commerce, retail stores, convenience stores and hypermarkets) across seven regions (Europe, East Asia, South Asia, Oceania, North America, Latin America, MEA and Europe).

Explore Extensive Coverage of FMI's Packaging Devices Landscape

Temperature Controlled Packaging Solutions Market – Obtain valuable insights on global temperature controlled packaging solutions market with exhaustive segmental analysis, market statistics, key influencing factors, prominent players and critical developmental strategies adopted by them for a predefined projection period.

Plastic Caps and Closures Market – FMI's report on plastic caps and closures market offers an in-depth commentary on the market poised for prolific growth during 2019-2029. The study covers comprehensive evaluation of key impacting forces, revenue sources, market leaders along with instrumental market strategies.

Beverage Packaging Market – Get a deep-dive analysis on beverage packaging market with crucial insights on growth levers, opportunities, restraints, regulatory policies, regional market forecast and key forte of market leaders.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.


Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries:
For Media Enquiries:
Market Report:
Press Release Source:
Packaging White Paper | February 2020

SOURCE: Future Market Insights

ReleaseID: 577140

Huawei Releases Best 5G Network to Empower Business Success

LONDON, ENGLAND / ACCESSWIRE / February 20, 2020 / At the Huawei product and solution launch in London, Peng Song, President of Huawei's Carrier BG Marketing and Solution Sales Dept, delivered a keynote. During this keynote, he announced the release of a cutting-edge 5G network, which is intended to help operators achieve commercial 5G success.

As a Chinese saying goes, "to become rich, you must first build a road". Likewise, operators' commercial 5G success must be built upon the most advanced 5G network that is simplified, smart, eco-friendly, and supports ultra-high bandwidth and end-to-end AI.

The cutting-edge 5G network released at the event is not just for show. It includes a series of product solutions, such as the simplified radio access network (RAN), smart IP network, ultra-high-bandwidth transport network, green connections, and AI-enabled end-to-end 5G services.

Simplified RAN accelerates 5G deployment: The simplified RAN features three product solutions: the industry's lightest 3rd-generation Massive MIMO antenna; the Blade AAU with the industry's highest level of integration; and a 400 MHz ultra-wideband AAU. These solutions address pain points during installation, site acquisition, and scattered frequency bands to help operators rapidly deploy 5G. The 3rd-generation Massive MIMO antenna, supporting 64T64R, is both light and easy to install. The Blade AAU supports active and passive integration under all sub-6 GHz frequency bands, significantly shortening the time required for site acquisition. The 400 MHz ultra-wideband AAU is an entire generation ahead of the rest of the industry.
Smart IP network leads the industry in supporting committable SLA: Through this solution, best-effort IP networks can be transformed into SLA-committable IP networks. With FlexE-based flexible network slicing, the smart IP network boasts the industry's highest slicing precision, at 1 Gbit/s. This is 5 times the industry average. Working with the Network Cloud Engine (NCE) and using SRv6, the smart IP network is the first in the industry to support committable latency. The solution also utilizes In-situ Flow Information Telemetry (iFIT), meaning faults can be located in minutes and the network is highly available.
Ultra-high-bandwidth transport network with the industry's first 800G module: This solution provides a transmission capacity of 48 Tbit/s on a single optical fiber, 40% higher than the industry average. This will ensure the transport network can evolve smoothly over the next 10 years.
Green connections lower the power consumption of 5G sites: The 5G AAU uses Huawei's proprietary highly integrated chips, reducing power consumption by more than 15%. The AI-enabled PowerStar solution also supports multi-standard, multi-frequency-band coordination, lowing the power consumption of the entire network by an additional 15% to 20%.
AI-enabled, end-to-end 5G delivery opens the way to a digital, intelligent era: AI is applied to the full life cycle management of 5G. This ensures network planning becomes more precise for better user experience, network construction becomes more agile for higher quality, services marketed to users are more targeted, and user experience issues are addressed more rapidly.

"The cutting-edge 5G network we released today is just a tip of the iceberg," says Peng Song, "We consistently invest in areas such as basic theories, materials, and algorithms to develop leading products and solutions for the industry and help operators achieve commercial 5G success."

About Huawei

Huawei is a leading global provider of information and communications technology (ICT) infrastructure and smart devices. With integrated solutions across four key domains – telecom networks, IT, smart devices, and cloud services – we are committed to bringing digital to every person, home and organization for a fully connected, intelligent world.

Huawei's end-to-end portfolio of products, solutions and services are both competitive and secure. Through open collaboration with ecosystem partners, we create lasting value for our customers, working to empower people, enrich home life, and inspire innovation in organizations of all shapes and sizes.

At Huawei, innovation focuses on customer needs. We invest heavily in basic research, concentrating on technological breakthroughs that drive the world forward. We have more than 188,000 employees by the end of 2018, and we operate in more than 170 countries and regions. Founded in 1987, Huawei is a private company fully owned by its employees.

For more information, please visit Huawei online at or follow us on:

Isabel Zhang

SOURCE: Huawei

ReleaseID: 577144

Adiponitrile Market to Cross US$ 12 Bn by 2029, Driven by Strong Demand for Polymer Nylon 6-6, Concludes Fact.MR in a New Study

Growing scope of application in automotive and textile production remains a key contributor to the adiponitrile market. This is further supported by the trend of replacing conventional materials.

DUBLIN, IRELAND / ACCESSWIRE / February 20, 2020 / The global adiponitrile market is set to surpass a valuation of US$ 12 Bn by the end of 2026, as per the findings of a recent market intelligence study of Fact.MR. Businesses in the adiponitrile market are increasingly pushing for expansion of production capacities and strategic pricing to keep up with the competition.

"The demand for hexamethylene diamine has grown strongly in the past five years and remains a significant driving factor. Asia remains a hot spot for new investments owing to increasing consumption of engineering resins across the region," says the Fact.MR report.

Request PDF Sample of 250+ pages report on the adiponitrile market-

Adiponitrile Market: Key Findings

Application in nylon synthesis continues to account for more than 85% of the global market value.
Automotive applications continue to hold dominance in adiponitrile market for production of materials and components.
Sales remain higher in developed regions, while East Asian market will display a faster rate of growth.
Major manufacturers are pushing operations to the Asia Pacific, for cost benefit.
Raw material pricing continues to be a key factor influencing industrial developments.

Adiponitrile Market: Key Driving Factors

Strong demand for polymer nylon 6-6 is the primary driver for growth of the adiponitrile market.
Demand for tire cords in the global automotive sector is generating lucrative opportunities for growth.
Application in production of lithium ion battery and hexamethylene diisocyanate (HDI) contributes to growth.

Adiponitrile: Key Market Restraints

Fluctuations in raw material prices is a key constraint for the global adiponitrile market.
Cut throat pricing rivalry among competing manufacturers cuts in to profitability, thereby limiting market growth.

Explore 152 figures, 108 tables in the study. Request ToC of the report at-

Competition Landscape

The global adiponitrile market is largely consolidated. Industry leaders are focusing their efforts on developing competitive pricing strategies for their offerings. This includes installation of new production facilities or expanding existing ones, with greater emphasis on the Asia Pacific region. The report has also profiled some of the key players in global adiponitrile market, including but not limited to Rhodia, Invista, and Ascend Performance Materials.

About the Report

This 250+ pages study provides detailed forecast data on the adiponitrile market. The key categories covered in the report include application (nylon synthesis, hexamethylene diisocyanates (HDI), electrolyte solution, and others), end use (chemical intermediate, automotive, electronics, textiles, and others) and 25+ countries in key regions (North America, Latin America, Europe, East Asia, South Asia & Oceania, and Middle East & Africa).

Explore Fact.MR's Detailed Coverage of the Chemicals & Materials Landscape

Polyaryletherketone (PAEK) Market – This research report provides a comprehensive range of insights which identify revenue sectors, key strategies, and potential growth opportunities, associated with polyaryletherketone (PAEK).

Conductive Textile Market – This report includes a detailed analysis on competitive scenarios, and essential information on major players in the conductive textile market.

Triethanolamine Market – This write up encompasses detailed secondary research, which is used to estimate key industry players and overall size of the triethanolamine market, and relevant industry associations.

About Fact.MR

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at Fact.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over thousand reports and 1 million+ data points, the team has scrutinized the Chemicals & Materials sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
Blog –


ReleaseID: 577137

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Investigation of Groupon, Inc. (GRPN)

NEW YORK, NY / ACCESSWIRE / February 20, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Groupon, Inc. ("Groupon" or the "Company") (NASDAQ:GRPN). Investors who purchased Groupon securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:

The investigation concerns whether Groupon and certain of its officers and/or directors have violated federal securities laws.

On February 18, 2020, Groupon announced its fourth quarter 2019 sales of $612.3 million, roughly a 23% drop over the past year. The company also adjusted EBITDA for the 2019 fiscal year of $227.2 million, well below its November 2019 estimated financial projection of $270 million. Following this news, Groupon stock dropped $1.21 per share, or over 39%, during intraday trading on February 19, 2020.

If you are aware of any facts relating to this investigation, or purchased Groupon shares, you can assist this investigation by visiting the firm's site: You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.


Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 |

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 577108

HYPERTENSION DIAGNOSTICS Inc., (HDII) Meeting with Shanghai CinTel Intelligent Ltd.

TORONTO, ON / ACCESSWIRE / February 20, 2020 / Mr. Peng Liangjian, CEO of Hypertension Diagnostics Inc. (OTC PINK:HDII), had a meeting with Mr. Zheng Ding, the chairman of Shanghai CinTel Intelligent Ltd. (CinTel) on February 14, 2020. Mr. Peng introduced Hypertension Diagnostics Inc (HDII) and US Stock Markets to Cintel. Mr. Ding is interested in North American capital markets, and the two discussed the possibilities of bringing the China based company to the U.S. stock markets.

About Shanghai CinTel Intelligent Ltd.

Shanghai CinTel Intelligent Ltd. was established in July 1998, focusing on the deep integration of big data, AI and IoT application technologies. It is a provider of intelligent communication services, big data applications and IoT application solutions. Based on the combination of independent research and development core technology and open source technology, CinTel has created a smart convergence business support platform and a one-stop big data analysis platform.

About Hypertension Diagnostics Inc.

Hypertension Diagnostics, Inc. is a public company currently trading on the OTC Markets (OTC: HDII). HDII was originally corporate in Minnesota .

*Safe Harbor Statement Information in this press release may contain 'forward-looking statements.' Statements describing objectives or goals or the Company's future plans are also forward-looking statements and are subject to risks and uncertainties, including the financial performance of the Company and market valuations of its stock, which could cause actual results to differ materially from those anticipated. Forward-looking statements in this news release are made pursuant to the 'Safe Harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to sales, acceptance of Hypertension Diagnostics Inc.'s products, increased levels of competition, changes, dependence on intellectual property rights and other risks detailed from time to time in Hypertension Diagnostic Inc. periodic reports filed with the regulatory authorities.

Jeff Peng

SOURCE: Hypertension Diagnostics Inc.

ReleaseID: 577143